Brevan Howard Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,473
Closed -$258K 1441
2024
Q4
$258K Buy
+13,473
New +$258K ﹤0.01% 799